TERN Awarded $11.26 Million U.S. Army Contract to Deploy Next Generation Positioning, Navigation, and Vehicle Readiness SystemsBusiness Wire • 09/10/26
Terns Pharmaceuticals Announces FDA Breakthrough Therapy Designation Granted to TERN-701 for Certain Patients with Chronic Myeloid LeukemiaGlobeNewsWire • 04/27/26
Merck Announces Expiration of Hart-Scott-Rodino Act Waiting Period to Acquire Terns Pharmaceuticals, Inc.Business Wire • 04/24/26
Terns Pharmaceuticals Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Terns Pharmaceuticals, Inc. - TERNBusiness Wire • 04/10/26
Shareholder Alert: Ademi LLP investigates whether Terns Pharmaceuticals Inc. is obtaining a Fair Price for Public ShareholdersGlobeNewsWire • 04/07/26
Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4)GlobeNewsWire • 04/02/26
Merck to Boost Oncology Pipeline With $6.7B Terns Buyout, Stock UpZacks Investment Research • 03/26/26
$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Terns Pharmaceuticals, Inc. (NASDAQ: TERN)PRNewsWire • 03/25/26
Merck's $6.7 Billion Terns Pharmaceuticals Acquisition May Face Rival Interest: AnalystBenzinga • 03/25/26
Shareholder Alert: The Ademi Firm investigates whether Terns Pharmaceuticals Inc. is obtaining a Fair Price for Public ShareholdersPRNewsWire • 03/25/26
TERN Stock Alert: Halper Sadeh LLC is Investigating Whether Terns Pharmaceuticals, Inc. is Obtaining a Fair Price for its ShareholdersBusiness Wire • 03/25/26
Merck to Acquire Terns Pharmaceuticals, Inc., Expanding Its Hematology Pipeline With TERN-701, a Novel Candidate for Chronic Myeloid Leukemia (CML)GlobeNewsWire • 03/25/26
As Terns Stock Soars 1,400%, What Does One Fund's $5.2 Million Sale Signal to Investors?The Motley Fool • 03/23/26
This Biotech Fund Sold $8 Million of Terns Stock Last Quarter, but Here's Why It Still Seems Very BullishThe Motley Fool • 03/18/26
This Biotech Attracted a $181 Million Investment During a Staggering 1,300% Stock RallyThe Motley Fool • 03/16/26